A cloud of uncertainty has settled over Europe’s CBD industry after the European Union’s executive body said it had taken the preliminary view that cannabidiol extracted from cannabis flowers should be considered a narcotic. With a potential blanket ban on CBD in food looming on the horizon, the impact of recent regulations in Austria offer […]
Uruguay is making it easier to export marijuana and hemp by eliminating the requirement that plants be registered first as medicine. But the change signed by President Lacalle Pou applies only to crops grown from 2018 to this year. Deputy Secretary of the Presidency Rodrigo Ferrés announced the actions late last week. Uruguay distinguishes marijuana […]
Hemp farmers are seeing an ally in U.S. Sen. Chuck Schumer, a Democrat from New York and the U.S. Senate Minority Leader, who is pushing federal agriculture officials to delay enforcing new hemp production rules until 2022. Schumer asked the U.S. Department of Agriculture on Friday to delay issuing the final rules for the U.S. […]
Federal agriculture officials have approved hemp production plans last week for one additional state and one American Indian Tribe. The U.S. Department of Agriculture gave the green light to plans from the state of Maryland and the Lower Sioux Indian Community in Minnesota. The two new approved plans bring the USDA’s tally of approved state, […]
Khiron Life Sciences, a vertically intergrated Colombian cannabis company, has signed a deal to sell its CBD skincare products in the Hong Kong region later this year. Khiron signed the distribution agreement for its Kuida CBD skincare line with DNO Group, an Asia-Pacific distributor with a network of more than 50,000 retail and online channels […]
Hemp and CBD leaders told Hemp Industry Daily what they hope to see in the FDA’s Enforcement Policy draft guidance, when the industry will likely get to see that document and what will happen to the industry if FDA regulatory guidance on CBD doesn’t come soon. (Click on the orange arrows to advance the slideshow.) […]
United Kingdom-based GW Pharmaceuticals posted marginal revenue growth in the second quarter over the previous quarter, citing challenges stemming from the COVID-19 pandemic. Epidiolex maker GW Pharma turns in flat second quarter on pandemic impact is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
The National Industrial Hemp Council and the National Association of State Departments of Agriculture say “many states will be unable to meet” the Oct. 31 deadline to switch to new rules for hemp production. In a letter to Congress this week, the organizations ask that implementation of the U.S. Department of Agriculture’s interim final rule, […]
CBD products in the U.S. have gotten cheaper over the last year, driven by falling prices for hemp biomass, reduced production expenses, and plans to reach consumers with less disposable income as unemployment numbers soar amid COVID-19. The aggregate price of hemp CBD biomass dropped by 79% from April 2019 to April 2020, according to […]
CV Sciences Inc., a San Diego-based CBD manufacturer, reported $5.4 million in revenue for the fiscal quarter that ended June 30 – a massive drop from the $16.9 million it reported during the same period in 2019. The revenue decline represents a 68% decrease from the same quarter last year, according to the company’s latest […]
